The broad tissue distribution of SREBP1 and its critical role in metabolism, particularly in the liver, makes rigorous toxicology assessments and tissue-selective drug delivery approaches the crucial early steps in the development of these small molecules for the prevention or treatment of cancers. The gene discussed is SREBF1; the disease is cancer.